Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Benefit of Palliative Primary Tumor Resection and Systemic Therapy Versus Systemic Therapy Only Among Patients With Stage IV Colorectal Carcinoma

NCT06326619 is registered in ClinicalTrials.gov with Medizinische Hochschule Brandenburg Theodor Fontane as lead sponsor.

NCT NCT06326619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06326619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Benefit of Palliative Primary Tumor Resection and Systemic Therapy Versus Systemic Therapy Only Among Patients With Stage IV Colorectal Carcinoma
Lead sponsor
Medizinische Hochschule Brandenburg Theodor Fontane
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 31, 2020
Enrollment
480 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, neoadjuvant systemic therapy